These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 2157234)
1. CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Schalla WO; Hearn TL; Taylor RN; Eavenson E; Valdiserri RO; Essien JD Public Health Rep; 1990; 105(2):167-71. PubMed ID: 2157234 [TBL] [Abstract][Full Text] [Related]
2. Centers for Disease Control perspective on quality assurance for human immunodeficiency virus type 1 antibody testing. Model Performance Evaluation Program. Valdiserri RO; Taylor RN; Hearn TL; Schalla WO; Muir HW Arch Pathol Lab Med; 1990 Mar; 114(3):263-7. PubMed ID: 2154961 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the impact of a CD4+ T-cell testing laboratory improvement program. Rosner E; Siragusa M; Schalla W; Cross D; Cohn R; Hearn T Arch Pathol Lab Med; 1998 Jun; 122(6):512-9. PubMed ID: 9625418 [TBL] [Abstract][Full Text] [Related]
4. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Variables associated in multivariate analyses. Gerber AR; Valdiserri RO; Johnson CA; Schwartz RE; Hancock JS; Hearn TL Arch Pathol Lab Med; 1991 Nov; 115(11):1091-6. PubMed ID: 1747026 [TBL] [Abstract][Full Text] [Related]
5. HIV safety guidelines and laboratory training. NIOSH. Collins CL; Mullan RJ; Moseley RR Public Health Rep; 1991; 106(6):727-32. PubMed ID: 1659723 [TBL] [Abstract][Full Text] [Related]
6. Analytic results of HIV-1 testing using blind proficiency testing. Peddecord KM; Benenson AS; Hofherr LK; Francis DP; Garfein RS; Ferran KL; Taylor RN; Schalla WO; Ascher MS Clin Lab Sci; 1992; 5(3):165-71. PubMed ID: 10147724 [TBL] [Abstract][Full Text] [Related]
7. Interpretive criteria used to report western blot results for HIV-1-antibody testing--United States. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1991 Oct; 40(40):692-5. PubMed ID: 1656186 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the implementation of HIV-rapid test kits at different levels of health institutions in Ethiopia. Tegbaru B; Wolday D; Messele T; Meless H; Kassa D; Tesema D; Tamene W; Ahmedin Z; Adane A; Tebeje M; Gezahegn N; Birhanu H; Mengistu Y; Wuhib T; Fekadu M Ethiop Med J; 2007 Jul; 45(3):293-9. PubMed ID: 18330330 [TBL] [Abstract][Full Text] [Related]
9. Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. Cross GD; Schalla WO; Hancock JS; Hearn TL; Blumer SO; Taylor RN; Valdiserri RO Arch Pathol Lab Med; 1992 May; 116(5):477-81. PubMed ID: 1580749 [TBL] [Abstract][Full Text] [Related]
10. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education. Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879 [TBL] [Abstract][Full Text] [Related]
11. Methods for a model blind proficiency testing system. Hofherr LK; Peddecord KM; Benenson AS; Garfein RS; Francis DP; Ferran KL; Taylor RN Clin Lab Sci; 1992; 5(3):160-4. PubMed ID: 10147723 [TBL] [Abstract][Full Text] [Related]
12. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Identification of variables associated with laboratory performance. Hancock JS; Taylor RN; Johnson CA; Gerber AR; Schalla WO Arch Pathol Lab Med; 1993 Nov; 117(11):1148-55. PubMed ID: 8239938 [TBL] [Abstract][Full Text] [Related]
13. CDC recommends all States make anonymous HIV testing available. Centers for Disease Control and Prevention. AIDS Alert; 1999 Jan; 14(1):1-3. PubMed ID: 11366086 [TBL] [Abstract][Full Text] [Related]
14. Communicating surveillance, epidemiologic, and laboratory information on HIV infection and AIDS. Greenspan AL; Curran JW Public Health Rep; 1991; 106(6):721-6. PubMed ID: 1659722 [TBL] [Abstract][Full Text] [Related]
16. HIV testing--United States, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2003 Jun; 52(23):540-5. PubMed ID: 12803192 [TBL] [Abstract][Full Text] [Related]
17. The family of HIV seroprevalence surveys: objectives, methods, and uses of sentinel surveillance for HIV in the United States. Pappaioanou M; Dondero TJ; Petersen LR; Onorato IM; Sanchez CD; Curran JW Public Health Rep; 1990; 105(2):113-9. PubMed ID: 2157233 [TBL] [Abstract][Full Text] [Related]
18. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Myers GL; Cooper GR; Winn CL; Smith SJ Clin Lab Med; 1989 Mar; 9(1):105-35. PubMed ID: 2538292 [TBL] [Abstract][Full Text] [Related]
19. Performance assessment of neonatal dried blood spot testing for HIV antibody. Parry JV; Mortimer PP; Nicoll AG Commun Dis Rep CDR Rev; 1992 Oct; 2(11):R128-30. PubMed ID: 1284932 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 proficiency testing. The American Association of Blood Banks/College of American Pathologists Program. Polesky HF; Hanson MR Arch Pathol Lab Med; 1990 Mar; 114(3):268-71. PubMed ID: 2407215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]